Company Filing History:
Years Active: 2019
Title: Thor Wagner: Innovator in HIV Research
Introduction
Thor Wagner is a prominent inventor based in Seattle, WA, known for his groundbreaking work in the field of HIV research. With a focus on genetic modification of T-cells, Wagner has made significant contributions to the development of therapies aimed at combating HIV.
Latest Patents
Wagner holds a patent for "CCR5 disruption of cells expressing anti-HIV chimeric antigen receptor (CAR) derived from broadly neutralizing antibodies." This patent relates to methods of genetically modifying T-cells to lack a co-receptor for HIV. The application also covers methods for creating nucleic acids encoding a chimeric antigen receptor and genetically modified T-cells that can be used in treating, inhibiting, or ameliorating HIV in subjects.
Career Highlights
Wagner is affiliated with Seattle Children's Hospital, where he continues to advance his research and innovation in the field of immunology. His work has the potential to change the landscape of HIV treatment and improve the lives of many individuals affected by the virus.
Collaborations
Wagner collaborates with esteemed colleagues such as Andrew M. Scharenberg and David J. Rawlings, who share his commitment to advancing medical science and developing effective therapies for HIV.
Conclusion
Thor Wagner's innovative approach to HIV research exemplifies the impact of genetic engineering in medicine. His contributions are paving the way for new treatment options and hold promise for future advancements in the fight against HIV.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.